ACTIVE

Biolynx (SRL)

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
100,8 k €
-60.3% YoY
Gross margin
432,9 k €
-25.3% YoY
Equity
586,1 k €
-20.8% YoY

What does Biolynx do?

Biolynx is a Private limited company incorporated in 2015. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0628.875.744
Incorporation
24/04/2015
Legal form
Private limited company
Registered office
Boomstraat 62A
9000 Gent · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Activities (NACE)
72109Research and experimental development on natural sciences and engineering· main72190Other research and experimental development on natural sciences and engineering71209Technical testing and analysis71209Technical testing and analysis
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 9 financial years

202520242023202220212020201920182017
Income statement
Gross margin432,9 k €579,9 k €489 k €310,5 k €232,9 k €116,6 k €-36,8 k €21,3 k €110,3 k €
EBITDA163,9 k €355,1 k €277,3 k €166 k €177,4 k €97,6 k €-38,2 k €20,5 k €109,4 k €
Operating result111 k €313,1 k €243,6 k €146 k €165,9 k €89,9 k €-50,9 k €7,7 k €96 k €
Net result100,8 k €254,3 k €188,5 k €128,9 k €147,3 k €83,9 k €-55,3 k €3 k €104,7 k €
Balance sheet
Equity586,1 k €740,2 k €498,3 k €324,5 k €301,2 k €197,1 k €114,1 k €169,4 k €167,4 k €
Total assets1,5 M €1,4 M €813,7 k €820,2 k €675,8 k €347,9 k €200,8 k €258,3 k €336,2 k €
Cash194 k €79 k €173,5 k €247 k €328 k €227,4 k €144,1 k €178 k €226,9 k €
Debts418,9 k €242,8 k €245,3 k €260,2 k €170,5 k €102,6 k €83,8 k €80,1 k €84 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Bart Kregersman

Director

Active

Ended mandates

Bart Kregersman

Manager

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date11/05/202611/06/202527/06/202419/06/202314/06/202211/06/2021
General meeting20/04/202617/05/202518/06/202420/05/202321/05/202215/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

10 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202520/04/202611/05/2026DutchPDF
Micro model31/12/202417/05/202511/06/2025DutchPDF
Micro model31/12/202318/06/202427/06/2024DutchPDF
Micro model31/12/202220/05/202319/06/2023DutchPDF
Micro model31/12/202121/05/202214/06/2022DutchPDF
Micro model31/12/202015/05/202111/06/2021DutchPDF
Micro model31/12/201920/06/202003/07/2020DutchPDF
Micro model31/12/201818/05/201918/06/2019DutchPDF
Micro model31/12/201719/05/201830/05/2018DutchPDF
Abridged model31/12/201620/05/201724/05/2017DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Bart Kregersman

Director

Active

Ended mandates

Bart Kregersman

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates10/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office16/02/2018
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other19/12/2016
    DIVERSEN
    PDF
  • Other28/04/2015
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025100,8 k €↓
  2. 2024
    Annual accounts 2024254,3 k €↑
  3. 2023
    Annual accounts 2023188,5 k €↑
  4. 2023
    Name changeBiolynx
  5. 2022
    Annual accounts 2022128,9 k €↓
  6. 2021
    Annual accounts 2021147,3 k €↑
  7. 2021
    Name changeKrechnologies
  8. 2020
    Annual accounts 202083,9 k €↑
  9. 2019
    Annual accounts 2019-55,3 k €↓
  10. 2018
    Annual accounts 20183 k €↓
  11. 2017
    Annual accounts 2017104,7 k €
  12. 24/04/2015
    IncorporationPrivate limited company